haloperidol and carbostyril

haloperidol has been researched along with carbostyril in 141 studies

Research

Studies (141)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (5.67)	18.2507
2000's	73 (51.77)	29.6817
2010's	58 (41.13)	24.3611
2020's	2 (1.42)	2.80

Authors

Authors	Studies
Kito, S; Semba, J; Toru, M; Watanabe, A	1
Domae, M; Furukawa, T; Inoue, T; Yamada, K	1
Fukamauchi, F; Kito, S; Mataga, N; Miyoshi, R; Sakai, M; Semba, J	1
Inoue, A; Kikuchi, T; Miki, S; Misu, Y; Morita, S; Nakata, Y; Seto, M; Ueda, H	1
Hide, I; Hirose, T; Inoue, A; Kikuchi, T; Koga, N; Nakata, Y; Seto, M; Sugita, S	1
Konieczny, J; Lorenc-Koci, E; Ossowska, K; Wolfarth, S	1
Inoue, A; Nakata, Y	1
Coper, H; Konieczny, J; Ossowska, K; Schulze, G; Wolfarth, S	1
Hashimoto, K; Satoh, Y; Sugiyama, A	1
Ali, MW; Carson, WH; Ingenito, GG; Kane, JM; McQuade, RD; Saha, AR; Zimbroff, DL	1
Kalkman, HO; Loetscher, E	1
Ali, M; Iwamoto, T; Kaplita, S; Marcus, R; Marder, SR; McQuade, RD; Safferman, AZ; Saha, A; Stock, E	1
Woods, SW	1
Altar, CA; Burris, KD; Dunn, B; Hirose, T; Imaoka, T; Kikuchi, T; Miwa, T; Molinoff, PB; Nakai, M; Nakai, S; Okazaki, H; Tottori, K; Uwahodo, Y; Yamada, S	1
Ali, M; Archibald, D; Carson, WH; Ingenito, G; Kasper, S; Lerman, MN; Marcus, R; McQuade, RD; Pigott, T; Saha, A	1
Tamminga, CA	1
Dai, J; Ichikawa, J; Li, Z; Meltzer, HY	1
Bryois, Ch; Sahli, Ch	1
Fear, C	1
Lambert, M; Naber, D	1
Engberg, G; Erhardt, S; Linderholm, KR; Nilsson, LK; Schwieler, L	1
Vieta, E	1
Winter, AS; Witschy, JK	1
Cosi, C; Newman-Tancredi, A; Rollet, K; Tesori, V; Waget, A	1
Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K	1
Bruins Slot, LA; Kleven, MS; Newman-Tancredi, A	1
Abou-Gharbia, N; Bourin, M; Carson, W; Iwamoto, T; Marcus, R; McQuade, R; Sanchez, R; Stock, E; Swanink, R; Vieta, E	1
Baldessarini, RJ; Grant, MJ	1
Balit, CR; Isbister, GK; Kilham, HA	1
Fletcher, PJ; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE	1
Carson, WH; Citrome, L; Czobor, P; Hardy, S; Kostic, D; Marcus, R; McQuade, RD; Volavka, J	1
Bermack, JE; Debonnel, G	1
Assié, MB; Carilla-Durand, E; Cosi, C; Leduc, N; Maraval, M; Newman-Tancredi, A; Ormiere, AM	1
Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM	1
Gaszner, P	1
Cipriani, A; Geddes, JR; Rendell, JM	1
Andrezina, R; Carson, WH; Iwamoto, T; Josiassen, RC; Manos, G; Marcus, RN; Oren, DA; Stock, E	1
Andrezina, R; Carson, WH; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E	1
Barlow, KB; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE	1
Engel, JA; Fejgin, K; Klamer, D; Pålsson, E; Safonov, S; Svensson, L; Wass, C	1
Artigas, F; Bortolozzi, A; Celada, P; Díaz-Mataix, L; Toth, M	1
Limosin, F	1
Oldham, J	1
Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Allen, MH; Crandall, DT; Currier, GW; Daniel, DG; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Carson, WH; Crandall, DT; Eudicone, J; Kane, JM; Marcus, RN; Pikalov, A; Swyzen, W	1
Assis, LC; Barbosa, LM; Grandi, E; Quevedo, J; Rezin, GT; Streck, EL	1
Kessler, RM	1
Conley, RR; Jung, DU; Kelly, DL; Liu, KH; Seo, YS; Shim, JC; Shin, JG; Shon, JH	1
Deng, C; Han, M; Huang, XF; Newell, K; Zavitsanou, K	1
Lorenz, RA; Weinstein, B	1
Kantrowitz, JT; Srihari, VH; Tek, C	1
Guimarães, FS; Leite, JV; Moreira, FA	1
Eudicone, JM; Kim, E; Miller, DD; Pikalov, A	1
Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ	1
Hazra, M; Mamo, DC; Remington, G	1
Burne, TH; Deng, C; Han, M; Huang, XF; Newell, KA	1
Bianchi, F; Di Lorenzo, G; Leo, R; Razzini, C; Romeo, F; Siracusano, A; Tesauro, M; Zanasi, M	1
Dal-Pizzol, F; Gomes, KM; Martins, MR; Petronilho, FC; Quevedo, J; Streck, EL	1
Andreazza, AC; Kapczinski, F; Quevedo, J; Rosa, MI; Stertz, L; Streck, EL; Valvassori, SS	1
Arnt, J; Dahan, L; Haddjeri, N; Hertel, P; Husum, H; Mnie-Filali, O	1
Aliaga, M; Assié, MB; Barbara, M; Bardin, L; Carilla-Durand, E; Malfètes, N; Maraval, M; Newman-Tancredi, A	1
Furukawa, H; Kamei, H; Matsui, K; Murai, R; Nabeshima, T; Nagai, T; Noda, Y	1
Bogeski, M; Gogos, A; van den Buuse, M	1
Cretaz, E; Diniz, BS; Forlenza, OV	1
Carson, WH; Lowy, A; Marcus, RN; McQuade, RD; Oren, DA; Sanchez, R; Spiller, NH; Torbeyns, AF; Young, AH	1
Assunção-Talbott, S; Crandall, DT; Eudicone, JM; Glick, ID; Janicak, PG; Marcus, RN; Marder, SR; McQuade, RD	1
Cho, HY; Choi, SM; Ha, EK; Kim, YH; Lee, JG; Park, SW; Seo, MK	1
Deng, C; Han, M; Huang, XF	1
Assunção-Talbott, S; Eudicone, JM; Glick, ID; Mankoski, R; Marcus, RN; Tran, QV	1
Bueno, JR; Campos, JA; Chaves, A; de Abreu, PB; de Matos E Souza, FG; de Oliveira, IR; de Sena, EP; E Silva, JA; Elkis, H; Gattaz, WF; Louzã, MR	1
Carlström, EL; Jazin, E; Jiang, L; Saetre, P	1
Accordini, S; Artioli, P; Barale, F; Barbui, C; Beneduce, R; Berardi, D; Bertolazzi, G; Biancosino, B; Bisogno, A; Bivi, R; Bogetto, F; Boso, M; Bozzani, A; Bucolo, P; Casale, M; Cascone, L; Ciammella, L; Cicolini, A; Cipresso, G; Cipriani, A; Colombo, P; Dal Santo, B; De Francesco, M; Di Lorenzo, G; Di Munzio, W; Ducci, G; Erlicher, A; Esposito, E; Ferrannini, L; Ferrato, F; Ferro, A; Fragomeno, N; Frova, M; Gardellin, F; Garzotto, N; Giambartolomei, A; Giupponi, G; Grassi, L; Grazian, N; Grecu, L; Guerrini, G; Laddomada, F; Lazzarin, E; Lintas, C; Malchiodi, F; Malvini, L; Marchiaro, L; Marsilio, A; Mauri, MC; Mautone, A; Menchetti, M; Migliorini, G; Mollica, M; Moretti, D; Mulè, S; Nicholau, S; Nosè, F; Nosè, M; Occhionero, G; Pacilli, AM; Parise, VF; Pecchioli, S; Percudani, M; Piantato, E; Piazza, C; Pontarollo, F; Pycha, R; Quartesan, R; Rillosi, L; Risso, F; Rizzo, R; Rocca, P; Roma, S; Rossattini, M; Rossi, G; Sala, A; Santilli, C; Saraò, G; Sarnicola, A; Sartore, F; Scarone, S; Sciarma, T; Siracusano, A; Strizzolo, S; Tansella, M; Targa, G; Tasser, A; Tomasi, R; Travaglini, R; Veronese, A; Ziero, S	1
Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A	1
Inada, K; Ishigooka, J; Oshibuchi, H; Sugawara, H	1
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R	1
Foltz, R; Lamm, L; Lin, SN; Moody, DE; Newton, TF; Reid, MS	1
Bates, JA; Guo, Z; Kan, HJ; Kane, JM; Kim, E; Pikalov, A; Whitehead, R	1
Deng, C; du Bois, TM; Han, M; Huang, XF	1
Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV	1
Benedetti, AM; Frazee, LA; Leung, JG; Myers, N	1
Charntikov, S; Crawford, CA; Der-Ghazarian, T; McDougall, SA; Varela, FA	1
Akaike, A; Izumi, Y; Kume, T; Matsuo, T; Sawada, H; Takada-Takatori, Y; Wakita, S	1
Inada, K; Ishigooka, J; Oshibuchi, H	1
Baker, RA; Docherty, JP; Eudicone, J; Mankoski, R; Marcus, RN; Mathew, S; McQuade, RD	1
Kaneko, YS; Mori, K; Nagatsu, T; Nakashima, A; Ota, A; Ota, M; Takami, G	1
Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y	1
Girgis, RR; Lieberman, JA; Merrill, DB; Pikalov, A; Vorel, SR; Whitehead, R; You, M	1
Calcagno, E; Carli, M; Invernizzi, RW; Mainini, E; Mainolfi, P	1
Calas, AG; Goursaud, S; Hermans, E; Jeanjean, AP; Koener, B; Maloteaux, JM; Van De Stadt, M	1
Choi, SH; Hong, JP; Kim, JE; Lee, JS; Paik, KW; Yoo, HK; Yoon, SJ	1
Kim, LW; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Shin, BS	1
Gründer, G; Klomp, M; Schiffl, K; Schorn, H; Vernaleken, IB; Veselinović, T	1
Hashimoto, K; Iyo, M; Kanahara, N; Okamura, N; Sekine, Y; Tadokoro, S	1
Accordini, S; Barbui, C; Cipriani, A; Esposito, E; Girlanda, F; Nosè, M; Purgato, M; Stroup, S; Tansella, M; Veronese, A	1
Carlsson, A; Carlsson, ML; Johansson, AM; Rung, E; Rung, JP; Svensson, K	1
Barbato, A; D'Avanzo, B; Parabiaghi, A; Tettamanti, M	1
Boettger, S; Breitbart, W; Friedlander, M; Passik, S	1
Gründer, G; Gur, R; Hiemke, C; Schiffl, K; Schorn, H; Vernaleken, I; Veselinović, T; Zernig, G	1
De Carolis, L; Milella, MS; Nencini, P; Schepisi, C	1
Bertani, S; Carboni, L; Cavanni, P; Fratte, SD; Michielin, F; Negri, M; Oliosi, B	1
Eberhard, J; Fors, BM; Hansen, K; Lindström, E; Sapin, C	1
Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z	1
Bauer, LK; Januzzi, JL; Leskov, I; Mukherji, EH; Tanev, KS	1
Cho, HY; Fang, ZH; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Phuong, VT; Seo, MK	1
Body, S; Bradshaw, CM; de Bruin, N; den Boon, FS; Hampson, CL; Szabadi, E	1
Ikeda, R; Katagiri, N; Mizumura, S; Mizuno, M; Nemoto, T; Shiraga, N; Tohgi, N; Tsujino, N; Yamaguchi, T	1
Grohmann, R; Holl, AK; Letmaier, M; Painold, A; Vergin, H	1
Chung, YC; Huang, GB; Lee, KH; Park, CH; Park, MS; Park, TW; Tong, Z; Yang, JC	1
Johnsen, E; Kroken, RA	1
Chang, LR; Huang, WL	1
Alsop, DC; Dazzan, P; Handley, R; Johnston, A; Kapur, S; Marques, TR; McGuire, P; Mehta, MA; O'Gorman, R; Pariante, CM; Reinders, AA; Taylor, H; Williams, S; Zelaya, FO	1
Meltzer, HY; Porter, JH; Vunck, SA; Wiebelhaus, JM	1
Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E	1
Gründer, G; Gur, R; Hiemke, C; Schorn, H; Vernaleken, IB; Veselinovic, T; Zernig, G	1
Chung, YC; Huang, GB; Kim, MG; Oh, KY; Park, TW; Yang, JC; Zhao, T	1
Gyertyán, I; Kiss, B; Román, V; Sághy, K; Szombathelyi, Z	1
Adams, CE; Jones, H; Powney, MJ	1
Bienroth, M; Curtis, V; Debenham, M; George, M; Gonzalez, D; Jones, S; Pitsi, D	1
Cheung, C; Chua, SE; Collier, DA; Deng, W; Gong, Q; Huang, C; Jiang, L; Li, M; Li, T; Ma, X; McAlonan, GM; Sham, PC; Wang, Q; Wang, Y	1
Furuya, M; Horiguchi, J; Ieda, M; Liaury, K; Miyaoka, T; Takechi, M; Tsuchie, K; Wake, R	1
Golla, H; Perrar, KM; Voltz, R	1
Frisch, J; Hiemke, C; Holthoewer, D; Kirschbaum, KM; Schmitt, U	1
Accordini, S; Barbui, C; Cipriani, A; Girlanda, F; Nosè, M; Purgato, M; Tansella, M	1
Charntikov, S; Crawford, CA; Der-Ghazarian, T; Lee, RJ; McDougall, SA; Varela, FA	1
Horikawa, H; Kanba, S; Kato, TA; Mizoguchi, Y; Monji, A; Sato-Kasai, M; Seki, Y; Yoshiga, D	1
Bleickardt, CJ; Hodgson, RA; Hunter, JC; Jones, NT; Kazdoba, TM	1
Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Longo, BM; Marinho, EA; Oliveira-Lima, AJ; Santos, R; Wuo-Silva, R	1
Brown, R; Geddes, J; Taylor, MJ	1
Bahramzi, M; Campillo, A; Minassian, A; Vilke, GM; Wilson, MP	1
Eleméry, M; Faludi, G; Kovács, G; Szegő, A	1
Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T	1
Aguglia, E; Bianchini, O; Cannavò, D; De Ronchi, D; Nespeca, C; Porcelli, S; Serretti, A; Trappoli, A	1
De Santis, M; Deng, C; Huang, XF; Lian, J; Pan, B	1
Brust, TF; Hayes, MP; Roman, DL; Watts, VJ	1
Deng, C; Han, M; Hu, CH; Huang, XF; Pan, B	1
Brown, JB; Kadoyama, K; Kimura, G; Miki, I; Nakamura, T; Nisiguchi, K; Okuno, Y; Sakaeda, T	1
Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S	1
Funahashi, Y; Iga, JI; Kumon, H; Mori, H; Ochi, S; Ozaki, T; Ozaki, Y; Ueno, M; Ueno, SI; Yamazaki, K; Yoshino, Y	1

Reviews

22 review(s) available for haloperidol and carbostyril

Article	Year
[How do antipsychotics exert their effects on dopamine receptor subtypes?]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112, Issue:6 Topics: Animals; Antipsychotic Agents; Aripiprazole; Haloperidol; Piperazines; Quinolones; Rats; Receptors, Dopamine; RNA, Messenger	1998
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophrenia research, 2003, Jun-01, Volume: 61, Issue:2-3 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology	2003
Chlorpromazine equivalent doses for the newer atypical antipsychotics. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles	2003
[Psychotropics and weight gain]. Praxis, 2004, Aug-25, Volume: 93, Issue:35 Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain	2004
Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8 Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials, Phase III as Topic; Haloperidol; Humans; Meta-Analysis as Topic; Piperazines; Quinolones; Risperidone; Schizophrenia; Time Factors	2004
The treatment of mixed states and the risk of switching to depression. European psychiatry : the journal of the Association of European Psychiatrists, 2005, Volume: 20, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Health Education; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles	2005
Antipsychotic poisoning in young children: a systematic review. Drug safety, 2005, Volume: 28, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Chlorpromazine; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Infant; Infant, Newborn; Olanzapine; Pimozide; Piperazines; Poisoning; Quetiapine Fumarate; Quinolones; Risperidone	2005
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:11 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome	2005
Haloperidol alone or in combination for acute mania. The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid	2006
[The use of atypical antipsychotics in the long-term care of schizophrenia]. L'Encephale, 2006, Volume: 32 Pt 3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors	2006
Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophrenia research, 2007, Volume: 95, Issue:1-3 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Double-Blind Method; Haloperidol; Humans; Longitudinal Studies; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Treatment Outcome	2007
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome	2008
[The use of antipsychotics in patients with dementia]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome	2008
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Evidence-Based Medicine; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
[Action of amygdala dopamine and effect of antipsychotics]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2010, Volume: 30, Issue:2 Topics: Amygdala; Animals; Antipsychotic Agents; Aripiprazole; Catecholamines; Conditioning, Classical; Dopamine; Fear; Haloperidol; Humans; Piperazines; Quinolones; Rats; Schizophrenia; Schizophrenic Psychology; Stress, Psychological	2010
Is rational antipsychotic polytherapy feasible? A selective review. Current psychiatry reports, 2012, Volume: 14, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Drug Therapy, Combination; Haloperidol; Humans; Piperazines; Prolactin; Quinolones; Schizophrenia	2012
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Journal of affective disorders, 2013, Jan-25, Volume: 144, Issue:3 Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles	2013
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles	2012
[Pharmacological treatment of delirium in palliative care patients. A systematic literature review]. Schmerz (Berlin, Germany), 2013, Volume: 27, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Delirium; Evidence-Based Medicine; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Olanzapine; Palliative Care; Piperazines; Quinolones; Risk Factors	2013
Aripiprazole alone or in combination for acute mania. The Cochrane database of systematic reviews, 2013, Dec-17, Issue:12 Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid	2013
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. The American journal of psychiatry, 2020, 04-01, Volume: 177, Issue:4 Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes	2020

Trials

23 trial(s) available for haloperidol and carbostyril

Article	Year
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Weight; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Female; Haloperidol; Humans; Hyperprolactinemia; Long QT Syndrome; Male; Piperazines; Placebos; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome	2002
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:4 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Haloperidol; Humans; Long-Term Care; Male; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Quinolones; Recurrence; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2003
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. The British journal of psychiatry : the journal of mental science, 2005, Volume: 187 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2005
[Clinical observations with aripiprazole in schizophrenia]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2006, Volume: 8, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Patient Compliance; Piperazines; Quinolones; Schizophrenia; Single-Blind Method; Treatment Outcome	2006
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology, 2006, Volume: 188, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Withholding Treatment	2006
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Current medical research and opinion, 2006, Volume: 22, Issue:11 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Treatment Outcome	2006
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia	2007
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. The American journal of psychiatry, 2007, Volume: 164, Issue:9 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Placebos; Quinolones; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Sex Factors; Treatment Outcome	2007
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. The British journal of psychiatry : the journal of mental science, 2009, Volume: 194, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Endpoint Determination; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Young Adult	2009
Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. CNS spectrums, 2009, Volume: 14, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Treatment Outcome	2009
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia. Trials, 2009, May-15, Volume: 10 Topics: Antipsychotic Agents; Aripiprazole; Clinical Protocols; Clozapine; Drug Resistance; Drug Therapy, Combination; Government Regulation; Haloperidol; Humans; Italy; Piperazines; Prospective Studies; Quinolones; Research Design; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2009
Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials. Applied health economics and health policy, 2009, Volume: 7, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Cost-Benefit Analysis; Female; Haloperidol; Humans; Male; Piperazines; Quinolones; Schizophrenia; Treatment Outcome	2009
Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia. Schizophrenia research, 2010, Volume: 120, Issue:1-3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Social Behavior Disorders; Young Adult	2010
Aripiprazole versus haloperidol treatment in early-stage schizophrenia. Journal of psychiatric research, 2011, Volume: 45, Issue:6 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult	2011
Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones; Receptors, Dopamine D2; Risperidone; Single-Blind Method; Young Adult	2011
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quinolones; Schizophrenia	2011
The GiSAS study: rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia. Contemporary clinical trials, 2011, Volume: 32, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Italy; Logistic Models; Olanzapine; Patient Selection; Piperazines; Proportional Hazards Models; Quinolones; Research Design; Schizophrenia; Time Factors	2011
Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers. Psychopharmacology, 2011, Volume: 218, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine; Female; Haloperidol; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Reserpine; Single-Blind Method; Young Adult	2011
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial. International clinical psychopharmacology, 2012, Volume: 27, Issue:2 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Neurotoxicity Syndromes; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Severity of Illness Index; Sulpiride; Time Factors; Young Adult	2012
Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Human brain mapping, 2013, Volume: 34, Issue:2 Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Blood Pressure; Brain Mapping; Cerebrovascular Circulation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Piperazines; Psychomotor Agitation; Quinolones; Receptors, Dopamine D2; Young Adult	2013
Effects of antipsychotic treatment on cognition in healthy subjects. Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Aripiprazole; Attention; Brain; Cognition; Cognition Disorders; Dopamine Antagonists; Female; Haloperidol; Humans; Learning; Male; Middle Aged; Neurons; Piperazines; Quinolones; Reaction Time; Reserpine; Single-Blind Method; Young Adult	2013
Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:6 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognition; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Piperazines; Psychomotor Performance; Quinolones; Risperidone; Sulpiride; Treatment Outcome; Young Adult	2012
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Disease-Free Survival; Drug Resistance; Drug Therapy, Combination; Haloperidol; Humans; Italy; Kaplan-Meier Estimate; Linear Models; Multivariate Analysis; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome	2013

Other Studies

96 other study(ies) available for haloperidol and carbostyril

Article	Year
Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology, 1995, Volume: 34, Issue:7 Topics: Animals; Antipsychotic Agents; Aripiprazole; Autoreceptors; Behavior, Animal; Brain; Dopamine; Haloperidol; Male; Microdialysis; Neurons; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Time Factors	1995
Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1 Topics: Animals; Antipsychotic Agents; Aripiprazole; Azepines; Estradiol; Haloperidol; In Vitro Techniques; Male; Piperazines; Pituitary Gland, Anterior; Prolactin; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine	1996
Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochemistry international, 1996, Volume: 29, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain; Clozapine; Corpus Striatum; Fluphenazine; Genes, fos; Haloperidol; In Situ Hybridization; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinolones; Rats; RNA, Messenger; Septum Pellucidum; Sulpiride	1996
Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1 Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Dopamine Agonists; GTP Phosphohydrolases; Haloperidol; Male; Membranes; Neostriatum; Oligonucleotides, Antisense; Piperazines; Quinolones; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Up-Regulation	1997
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain research. Molecular brain research, 1998, Volume: 55, Issue:2 Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Cell Membrane; Gene Expression Regulation; Haloperidol; Male; Piperazines; Pituitary Gland; Prolactin; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Ribonucleases; RNA, Messenger; Spiperone	1998
The role of striatal glutamate receptors in models of Parkinson's disease. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: Animals; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Electromyography; Excitatory Amino Acid Antagonists; Haloperidol; Kynurenic Acid; Parkinson Disease; Quinolones; Rats; Receptors, N-Methyl-D-Aspartate; Reserpine	1998
L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats. Psychopharmacology, 1999, Volume: 143, Issue:3 Topics: Animals; Anti-Dyskinesia Agents; Catalepsy; Dopamine Antagonists; Electromyography; Excitatory Amino Acid Antagonists; Female; Haloperidol; Male; Muscle Rigidity; Muscle Tonus; Parkinson Disease, Secondary; Quinolones; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate	1999
In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol. Toxicology and applied pharmacology, 2001, Jun-01, Volume: 173, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Blood Pressure; Cardiac Output; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Haloperidol; Heart Rate; Hemodynamics; Piperazines; Quinolones; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure	2001
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. European journal of pharmacology, 2003, Feb-21, Volume: 462, Issue:1-3 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine	2003
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. European journal of pharmacology, 2003, Jul-04, Volume: 472, Issue:1-2 Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Corpus Striatum; Dopamine; Haloperidol; Limbic System; Male; Mice; Mice, Inbred ICR; Piperazines; Quinolones; Risperidone; Time Factors	2003
Similarities and differences among antipsychotics. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 17 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2003
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. European journal of pharmacology, 2004, Jun-16, Volume: 493, Issue:1-3 Topics: Acetylcholine; Animals; Antipsychotic Agents; Aripiprazole; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Haloperidol; Hippocampus; Male; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Pyridines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Antagonists	2004
[Expectations and developments in atypical antipsychotics]. Praxis, 2004, Aug-25, Volume: 93, Issue:35 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Clozapine; Diabetes Complications; Haloperidol; Humans; Obesity; Olanzapine; Piperazines; Quinolones; Risk Factors; Schizophrenia; Weight Gain	2004
Aripiprazole: novelty, adherence and understatement. The international journal of neuropsychopharmacology, 2005, Volume: 8, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Haloperidol; Humans; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Therapeutic Equivalency	2005
Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. The international journal of neuropsychopharmacology, 2005, Volume: 8, Issue:3 Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Butyrates; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Kynurenic Acid; Locus Coeruleus; Male; Neurons; Norepinephrine; Quinolones; Rats; Rats, Sprague-Dawley	2005
Improvement in tardive dyskinesia with aripiprazole use. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid	2005
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Brain research, 2005, May-10, Volume: 1043, Issue:1-2 Topics: Aminopyridines; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Piperazines; Piperidines; Pyridines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Thiazoles	2005
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium	2005
Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat. Neuropharmacology, 2005, Volume: 49, Issue:7 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Dioxanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Interpersonal Relations; Male; Phencyclidine; Piperazines; Pyridines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Remoxipride; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Tropanes	2005
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Delusions; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome	2005
Aripiprazole: new drug. Just another neuroleptic. Prescrire international, 2005, Volume: 14, Issue:79 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Drugs, Investigational; Haloperidol; Humans; Piperazines; Quinolones; Schizophrenia; Treatment Outcome	2005
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:9 Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Catalepsy; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Immunohistochemistry; Male; Motor Activity; Oncogene Proteins v-fos; Piperazines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone	2006
Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors. Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Anisoles; Antidepressive Agents; Autoreceptors; Brain; Haloperidol; Hypothalamus; Iontophoresis; Male; Piperazines; Presynaptic Terminals; Propylamines; Pyramidal Cells; Pyridines; Quinolones; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, sigma; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses	2007
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. European journal of pharmacology, 2006, Mar-27, Volume: 535, Issue:1-3 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Binding, Competitive; Cell Line; Clozapine; Dioxanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Male; Piperazines; Prolactin; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Spodoptera; Sulfur Radioisotopes; Tropanes	2006
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy, 2006, Volume: 26, Issue:6 Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Piperazines; Pituitary Neoplasms; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; United States; United States Food and Drug Administration	2006
Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:7 Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Biomarkers; Brain; Brain Chemistry; Catalepsy; Clozapine; Dopamine Agonists; Drug Evaluation, Preclinical; Haloperidol; Male; Piperazines; Prolactin; Proto-Oncogene Proteins c-fos; Psychotic Disorders; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Serotonin Antagonists; Treatment Outcome	2007
The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology, 2007, Volume: 191, Issue:2 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Haloperidol; Male; Mice; Neural Inhibition; Olanzapine; Phencyclidine; Piperazines; Quinolones; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia	2007
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology, 2007, Volume: 191, Issue:3 Topics: Action Potentials; Animals; Antipsychotic Agents; Aripiprazole; Autoreceptors; Brain; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Piperazines; Prefrontal Cortex; Quinolones; Raphe Nuclei; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Serotonin; Serotonin Receptor Agonists; Ventral Tegmental Area	2007
Violent behavior. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Commitment of Mentally Ill; Dangerous Behavior; Haloperidol; Humans; Male; Piperazines; Quinolones; Risk Factors; Students; Treatment Outcome; Universities; Violence; Virginia	2007
Intramuscular aripiprazole in the control of agitation. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2007
Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 376, Issue:1-2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Electron Transport Complex IV; Energy Metabolism; Haloperidol; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Wistar; Succinate Dehydrogenase	2007
Aripiprazole: what is the role of dopamine D(2) receptor partial agonism? The American journal of psychiatry, 2007, Volume: 164, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Haloperidol; Humans; Hyperprolactinemia; Piperazines; Quinolones; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission	2007
Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain. Journal of neuroscience research, 2008, Feb-01, Volume: 86, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Female; Haloperidol; In Situ Hybridization; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; RNA, Messenger; Time	2008
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid	2007
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders	2007
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. European journal of pharmacology, 2008, Jan-14, Volume: 578, Issue:2-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors	2008
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Incidence; Male; Middle Aged; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Retrospective Studies; Schizophrenia; Severity of Illness Index	2007
Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects. The American journal of psychiatry, 2008, Volume: 165, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Costs; Drug Therapy, Combination; Haloperidol; Humans; Hyperprolactinemia; Piperazines; Polypharmacy; Quinolones; Schizophrenia	2008
Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology, 2008, Volume: 33, Issue:5 Topics: Adipose Tissue; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Haloperidol; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; RNA, Messenger; Time Factors; Ventromedial Hypothalamic Nucleus; Weight Gain	2008
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Heart Conduction System; Humans; Long QT Syndrome; Piperazines; Quinolones; Schizophrenia	2008
Antipsychotic-induced oxidative stress in rat brain. Neurotoxicity research, 2008, Volume: 13, Issue:1 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Corpus Striatum; Haloperidol; Hippocampus; Male; Olanzapine; Oxidative Stress; Piperazines; Prefrontal Cortex; Quinolones; Rats; Rats, Wistar; Superoxides; Thiobarbituric Acid Reactive Substances	2008
Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats. Metabolic brain disease, 2008, Volume: 23, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Clozapine; Drug Administration Schedule; Haloperidol; Hippocampus; Male; Nerve Growth Factor; Olanzapine; Piperazines; Quinolones; Rats; Rats, Wistar; Time; Up-Regulation	2008
Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2 Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Aripiprazole; Benzoxazoles; Dopamine; Dopamine D2 Receptor Antagonists; Electroshock; Haloperidol; Male; Neurons; Piperazines; Pyridines; Quinolones; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Ultrasonics; Ventral Tegmental Area; Vocalization, Animal	2009
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benzofurans; Benzoxazoles; Benzylamines; Blood Glucose; Clozapine; Corticosterone; Cyclopentanes; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Thiazoles	2008
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology, 2009, Volume: 202, Issue:1-3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Haloperidol; Male; Memory Disorders; Mice; Mice, Inbred ICR; Motor Activity; Phencyclidine; Piperazines; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Recognition, Psychology	2009
Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behavioural pharmacology, 2008, Volume: 19, Issue:5-6 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred Strains; Olanzapine; Piperazines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reflex, Startle; Risperidone; Serotonin Receptor Agonists; Species Specificity	2008
Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:5 Topics: Analysis of Variance; Antipsychotic Agents; Aripiprazole; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Humans; Luciferases; Neuroblastoma; Piperazines; Proto-Oncogene Proteins c-bcl-2; Quinolones; Signal Transduction; Transfection	2009
Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:7 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Brain; Caudate Nucleus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gene Expression Regulation, Enzymologic; Haloperidol; Limbic System; Nucleus Accumbens; Olanzapine; Piperazines; Putamen; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation; Ventral Tegmental Area	2009
The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. Journal of affective disorders, 2009, Volume: 115, Issue:1-2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells. BMC pharmacology, 2009, Mar-31, Volume: 9 Topics: Alternative Splicing; Antipsychotic Agents; Aripiprazole; Astrocytoma; Benzodiazepines; Cell Line, Tumor; Clozapine; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; Risperidone; RNA-Binding Proteins; RNA, Messenger; Time Factors	2009
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. Behavioural brain research, 2009, Nov-05, Volume: 203, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording	2009
Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats. European journal of pharmacology, 2009, Aug-01, Volume: 615, Issue:1-3 Topics: Amygdala; Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Conditioning, Psychological; Dopamine; Dopamine D2 Receptor Antagonists; Electric Stimulation; Fear; Haloperidol; Male; Methamphetamine; Microdialysis; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stress, Psychological	2009
Use of aripiprazole in tardive dyskinesia: an open label study of six cases. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia	2009
A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma. Journal of analytical toxicology, 2009, Volume: 33, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Haloperidol; Humans; Middle Aged; Piperazines; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult	2009
The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain. Neuroscience, 2009, Dec-29, Volume: 164, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Female; Haloperidol; Limbic System; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; RNA, Messenger	2009
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Costs; Female; Haloperidol; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2011
Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:5 Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Autoreceptors; Brain Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Drug Interactions; Female; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2	2010
Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Ascorbic Acid; Biological Transport; Dopamine; Extracellular Space; Gene Expression Regulation, Enzymologic; Haloperidol; Homovanillic Acid; Mesencephalon; Neurons; Pargyline; PC12 Cells; Pimozide; Piperazines; Quinolones; Rats; Spiperone; Transport Vesicles; Tyrosine 3-Monooxygenase	2010
Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:10 Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Appetite Regulation; Aripiprazole; Fatty Acids; Haloperidol; Oxidative Phosphorylation; PC12 Cells; Piperazines; Potassium Channels; Quinolones; Rats; RNA, Messenger	2010
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents. Schizophrenia research, 2011, Volume: 125, Issue:1 Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia	2011
Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology, 2011, Volume: 214, Issue:3 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Choice Behavior; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Impulsive Behavior; Male; Microdialysis; Neuropsychological Tests; Olanzapine; Piperazines; Prefrontal Cortex; Quinolones; Rats; Reaction Time; Schizophrenia; Serotonin; Time Factors	2011
Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization. Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:1 Topics: Animals; Apomorphine; Aripiprazole; Buffers; Catalepsy; Cell Membrane; Cerebral Cortex; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Antagonism; Drug Partial Agonism; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Male; Piperazines; Piperidines; Pyridines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Stereotyped Behavior; Up-Regulation	2011
Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. European child & adolescent psychiatry, 2011, Volume: 20, Issue:3 Topics: Adolescent; Aripiprazole; Child; Female; Haloperidol; Humans; Male; Piperazines; Quinolones; Severity of Illness Index; Tic Disorders; Treatment Outcome	2011
Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. Neuroscience research, 2011, Volume: 69, Issue:4 Topics: 1-Methyl-4-phenylpyridinium; Animals; Antipsychotic Agents; Aripiprazole; bcl-2-Associated X Protein; Benzodiazepines; Blotting, Western; Cell Survival; Haloperidol; Herbicides; Olanzapine; Oxidative Stress; PC12 Cells; Piperazines; Quinolones; Rats; Reactive Oxygen Species; Superoxide Dismutase; Thiazoles	2011
Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis. Schizophrenia bulletin, 2012, Volume: 38, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Long-Term Care; Male; Methamphetamine; Motor Activity; Piperazines; Psychoses, Substance-Induced; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia	2012
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 384, Issue:1 Topics: Animals; Aripiprazole; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Hyperprolactinemia; Lactotrophs; Male; Methyltyrosines; Piperazines; Piperidines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine	2011
Aripiprazole and haloperidol in the treatment of delirium. The Australian and New Zealand journal of psychiatry, 2011, Volume: 45, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Databases, Factual; Delirium; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome	2011
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. Psychopharmacology, 2011, Volume: 218, Issue:4 Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley	2011
Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Piperazines; Prolactin; Quetiapine Fumarate; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2	2012
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden. Nordic journal of psychiatry, 2011, Volume: 65, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Models, Economic; National Health Programs; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sweden	2011
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2011, Volume: 13, Issue:3 Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology	2011
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. The American journal of psychiatry, 2011, Volume: 168, Issue:9 Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality Therapy; Cooperative Behavior; Electrocardiography; Electroconvulsive Therapy; Female; Haloperidol; Humans; Interdisciplinary Communication; Long QT Syndrome; Piperazines; Quinolones; Risk Factors; Torsades de Pointes	2011
Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress. Neuroscience research, 2011, Volume: 71, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; beta Catenin; Blotting, Western; Brain-Derived Neurotrophic Factor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Hippocampus; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Restraint, Physical; Schizophrenia; Stress, Psychological	2011
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9 Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Kinetics; Models, Biological; Motor Activity; Motor Skills; Piperazines; Quinolones; Rats; Rats, Wistar; Reaction Time; Reinforcement Schedule; Serotonin Antagonists; Sulpiride	2012
Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Brain; Brain Mapping; Catatonia; Cerebrovascular Circulation; Female; Haloperidol; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2011
Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Combinations; Drug Interactions; Female; Haloperidol; Humans; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Recurrence; Risperidone	2012
Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Diabetes Complications; Dibenzothiepins; Dopamine; Drug Interactions; Female; Haloperidol; Humans; Hyperhidrosis; Middle Aged; Piperazines; Quinolones; Schizophrenia	2012
Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. Behavioural pharmacology, 2012, Volume: 23, Issue:3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Discrimination Learning; Generalization, Psychological; Haloperidol; Male; Mice; Mice, Inbred C57BL; Piperazines; Quinolones	2012
Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats. Psychopharmacology, 2013, Volume: 226, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Secondary Prevention; Substance-Related Disorders	2013
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Tranquilizing Agents	2013
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment. Psychological medicine, 2013, Volume: 43, Issue:11 Topics: Adolescent; Adult; Anisotropy; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Brain Mapping; Case-Control Studies; Dibenzothiazepines; Diffusion Tensor Imaging; Female; Frontal Lobe; Gyrus Cinguli; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult	2013
The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia. Asian journal of psychiatry, 2013, Volume: 6, Issue:2 Topics: Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Haloperidol; Hyperbilirubinemia; Inhibition, Psychological; Locomotion; Male; Neuropsychological Tests; Piperazines; Quinolones; Rats; Rats, Gunn; Reflex, Startle; Risperidone; Schizophrenia; Social Behavior; Treatment Outcome	2013
Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties. Pharmacopsychiatry, 2013, Volume: 46, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buspirone; Haloperidol; Ketanserin; Male; Mice; Mice, Knockout; Motor Activity; Piperazines; Quinolones; Rotarod Performance Test; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles	2013
Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:4 Topics: Age Factors; Animals; Antipsychotic Agents; Aripiprazole; Binding Sites; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Time Factors; Up-Regulation	2014
Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model. Schizophrenia research, 2013, Volume: 151, Issue:1-3 Topics: Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Brain; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Interactions; Haloperidol; Interferon-gamma; Microglia; Minocycline; Myelin Proteolipid Protein; Nitrites; Oligodendroglia; Piperazines; Quinolinium Compounds; Quinolones; Rats; STAT1 Transcription Factor	2013
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model. Pharmacology, biochemistry, and behavior, 2014, Volume: 118 Topics: Adenosine A2 Receptor Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Cebus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Motor Activity; Phosphodiesterase Inhibitors; Piperazines; Pyrazoles; Pyrimidines; Quinolines; Quinolones; Triazoles	2014
Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Sensitization; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Mice; Motor Activity; Piperazines; Quinolones; Thiazoles	2014
Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. The Journal of emergency medicine, 2014, Volume: 46, Issue:6 Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles	2014
[Emergency psychopharmacotherapy in Hungary -- preliminary data]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2014, Volume: 16, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clopenthixol; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Treatment; Female; Haloperidol; Humans; Hungary; Male; Middle Aged; Olanzapine; Piperazines; Practice Patterns, Physicians'; Promethazine; Psychiatry; Psychomotor Agitation; Psychotic Disorders; Quinolones; Surveys and Questionnaires	2014
Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2014, Volume: 36, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Schizophrenia	2014
Effects of antipsychotic drugs on insight in schizophrenia. Psychiatry research, 2014, Aug-15, Volume: 218, Issue:1-2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Awareness; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Thiazoles	2014
Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats. Pharmacology, biochemistry, and behavior, 2014, Volume: 124 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Drinking Behavior; Feeding Behavior; Haloperidol; Male; Motor Activity; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Weight Gain	2014
New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling. Biochemical pharmacology, 2015, Jan-01, Volume: 93, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Haloperidol; HEK293 Cells; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Signal Transduction	2015
Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain. Psychiatry research, 2015, Feb-28, Volume: 225, Issue:3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebral Cortex; Female; Haloperidol; Hippocampus; Neuregulin-1; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, ErbB-4; Schizophrenia; Signal Transduction; Time Factors; Up-Regulation	2015
Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database. International journal of medical sciences, 2015, Volume: 12, Issue:2 Topics: Algorithms; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Mining; Databases, Factual; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles	2015
Gestational exposure to haloperidol changes Cdkn1a and Apaf1 mRNA expressions in mouse hippocampus. Brain research bulletin, 2023, Volume: 199 Topics: Animals; Antipsychotic Agents; Aripiprazole; Haloperidol; Hippocampus; Mice; Piperazines; Quinolones; RNA, Messenger	2023